InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Keenan Greg. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 6 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €247k. History available since 28 February 2025. The latest transaction was disclosed on 6 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Keenan Greg is a declarant linked to Aurinia Pharmaceuticals Inc. (XNAS), and the transaction volume observed in the sampled recent filings covers the period from 2025-03-04 to 2026-03-10. Across these 6 filings in total, buys are 0 EUR and sells are 247186 EUR, with Retenue fiscale as the most frequent transaction nature.